KEGG   DRUG: Prabotulinumtoxin A
Entry
D11405                      Drug                                   

Name
Prabotulinumtoxin A (USAN);
PrabotulinumtoxinA-xvfs;
Jeuveau (TN)
Product
Formula
C6760H10447N1743O2010S32
Exact mass
149228.9908
Mol weight
149320.8333
Class
Other
 DG02029  Muscle relaxant
  DG01696  Peripherally-acting muscle relaxant
   DG03117  Nondepolarizing neuromuscular blocking agent
Remark
ATC code: M03AX01
Chemical structure group: DG00772
Product (DG00772): D00783<JP/US> D02735<JP/US> D11405<US>
Efficacy
Skeletal muscle relaxant
Comment
Treatment of glabellar lines
Target
SNAP25 [HSA:6616] [KO:K18211]
  Pathway
hsa04721  Synaptic vesicle cycle
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 M MUSCULO-SKELETAL SYSTEM
  M03 MUSCLE RELAXANTS
   M03A MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
    M03AX Other muscle relaxants, peripherally acting agents
     M03AX01 Botulinum toxin
      D11405  Prabotulinumtoxin A (USAN) <US>
USP drug classification [BR:br08302]
 Dermatological Agents
  Dermatological Agents, Other
   Miscellaneous, dermatological
    Prabotulinumtoxin A
     D11405  Prabotulinumtoxin A (USAN)
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Organismal systems
   Nervous system
    SNAP25
     D11405  Prabotulinumtoxin A (USAN) <US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D11405
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11405
Other DBs
CAS: 93384-43-1
PubChem: 384585383
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system